RE: Excellent presentation30 Oct 2024 10:32
If I recall correctly, Parker was asked about barriers to striking a deal. He said there are 3 factors. 1- Data, 2- IP and 3 the financial terms. I believe it came across as 1 and 2 or nailed, and we have had offers but we don’t believe they are sufficient. Like a lot of people on here, I believe they have been asked to do the extended tox as a prerequisite to a more satisfactory offer. Tim did stress it would take longer than 16 weeks for review etc, nearer to 6 months. My thought is, if they are in advanced talks, then it’s unlikely the other side would wait for the data to be peer reviewed before sealing a deal. It’s likely that others will then show interest. Based on the fact we are financing the tox studies and can’t see how there could be a first dibs offer on the table if there has been no financial support. I’m hoping a deal will be struck shortly after the tox study is completed. Hope that makes sense.